Search research articles
Contact Us
Filters
Showing results (1241-1250 of 1,276) with videos related to
Page
of 128
Sort By:
Scientific Data
|
May 11, 2016
Daphnia magna transcriptome by RNA-Seq across 12 environmental stressors
Luisa Orsini, Donald Gilbert, Ram Podicheti, et al.
Vaccine
|
November 30, 2025
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination
Sharon E Frey, Lindsey R Baden, Hana M El Sahly, et al.
Kidney International
|
October 1, 2025
Changing paradigms of studies in kidney diseases
Adeera Levin, Allison Jaure, Dustin J Little, et al.
Journal of Medicinal Chemistry
|
September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)
Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Journal of Medicinal Chemistry
|
August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)
Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Frontiers in Aging Neuroscience
|
August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study
Adrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
AIDS (London, England)
|
March 15, 2024
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial
Trevor A Crowell, Justin Ritz, Lu Zheng, et al.
Nature Communications
|
January 8, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Christian J Maine, Shigeki J Miyake-Stoner, Darina S Spasova, et al.
The Journal of Infectious Diseases
|
August 8, 2018
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies
Golnaz Namazi, Jesse M Fajnzylber, Evgenia Aga, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
Nadine G Rouphael, Angela R Branche, David J Diemert, et al.
Page
of 128
Search research articles
Search
Showing results (1241-1250 of 1,276) with videos related to
Sort By:
Page
of 128
Scientific Data
|
May 11, 2016
Daphnia magna transcriptome by RNA-Seq across 12 environmental stressors
Luisa Orsini, Donald Gilbert, Ram Podicheti, et al.
Vaccine
|
November 30, 2025
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination
Sharon E Frey, Lindsey R Baden, Hana M El Sahly, et al.
Kidney International
|
October 1, 2025
Changing paradigms of studies in kidney diseases
Adeera Levin, Allison Jaure, Dustin J Little, et al.
Journal of Medicinal Chemistry
|
September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)
Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Journal of Medicinal Chemistry
|
August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)
Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Frontiers in Aging Neuroscience
|
August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study
Adrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
AIDS (London, England)
|
March 15, 2024
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial
Trevor A Crowell, Justin Ritz, Lu Zheng, et al.
Nature Communications
|
January 8, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Christian J Maine, Shigeki J Miyake-Stoner, Darina S Spasova, et al.
The Journal of Infectious Diseases
|
August 8, 2018
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies
Golnaz Namazi, Jesse M Fajnzylber, Evgenia Aga, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
Nadine G Rouphael, Angela R Branche, David J Diemert, et al.
Page
of 128